Literature DB >> 28947851

Community use of naloxone for opioid overdose.

Marianne E Jauncey1, Suzanne Nielsen2.   

Abstract

Entities:  

Year:  2017        PMID： 28947851      PMCID： PMC5601973          DOI： 10.18773/austprescr.2017.043

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  16 in total

1.  Preventing opiate overdose deaths: examining objections to take-home naloxone.

Authors:  Alexander R Bazazi; Nickolas D Zaller; Jeannia J Fu; Josiah D Rich
Journal:  J Health Care Poor Underserved       Date:  2010-11

2.  Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal.

Authors:  Phillip O Coffin; Sean D Sullivan
Journal:  Ann Intern Med       Date:  2013-01-01       Impact factor: 25.391

3.  Brief overdose education is sufficient for naloxone distribution to opioid users.

Authors:  Emily Behar; Glenn-Milo Santos; Eliza Wheeler; Christopher Rowe; Phillip O Coffin
Journal:  Drug Alcohol Depend       Date:  2014-12-19       Impact factor: 4.492

4.  Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal.

Authors:  Suzanne Nielsen; Nadia Menon; Sarah Larney; Michael Farrell; Louisa Degenhardt
Journal:  Addiction       Date:  2016-08-16       Impact factor: 6.526

Review 5.  A systematic review of community opioid overdose prevention and naloxone distribution programs.

Authors:  Angela K Clark; Christine M Wilder; Erin L Winstanley
Journal:  J Addict Med       Date:  2014 May-Jun       Impact factor: 3.702

6.  Naloxone reversal of buprenorphine-induced respiratory depression.

Authors:  T J Gal
Journal:  Clin Pharmacol Ther       Date:  1989-01       Impact factor: 6.875

7.  Findings and lessons learnt from implementing Australia's first health service based take-home naloxone program.

Authors:  Karen J Chronister; Nicholas Lintzeris; Anthony Jackson; Mihaela Ivan; Paul M Dietze; Simon Lenton; John Kearley; Ingrid van Beek
Journal:  Drug Alcohol Rev       Date:  2016-04-13

8.  Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis.

Authors:  Rebecca E Giglio; Guohua Li; Charles J DiMaggio
Journal:  Inj Epidemiol       Date:  2015-05-22

9.  Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.

Authors:  Eliza Wheeler; T Stephen Jones; Michael K Gilbert; Peter J Davidson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-06-19       Impact factor: 17.586

10.  Preventing deaths from rising opioid overdose in the US - the promise of naloxone antidote in community-based naloxone take-home programs.

Authors:  Michele M Straus; Udi E Ghitza; Betty Tai
Journal:  Subst Abuse Rehabil       Date:  2013-09-02
View more
  3 in total

1.  Barriers to and recommendations for take-home naloxone distribution: perspectives from opioid treatment programs in New Mexico.

Authors:  Julie G Salvador; Andrew L Sussman; Mikiko Y Takeda; William G Katzman; Monica Moya Balasch; Joanna G Katzman
Journal:  Harm Reduct J       Date:  2020-05-13

2.  Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial.

Authors:  Hannah Ellerbroek; Sandra A S van den Heuvel; Albert Dahan; Hans Timmerman; Cornelis Kramers; Arnt F A Schellekens
Journal:  Addict Sci Clin Pract       Date:  2022-09-04

3.  Engineering Quick- and Long-acting Naloxone Delivery Systems for Treating Opioid Overdose.

Authors:  Farrokh Sharifi; Yazan J Meqbil; Andrew Otte; Anna M Gutridge; Arryn T Blaine; Richard M van Rijn; Kinam Park
Journal:  Pharm Res       Date:  2021-06-10       Impact factor: 4.580
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.